Newsletters Joni Henderson 11/20/25 Joni Henderson 11/20/25 CTAD 2025 Read More Joni Henderson 11/5/25 Joni Henderson 11/5/25 C2N Makes Many Moves as It Advances Science Read More Joni Henderson 7/23/25 Joni Henderson 7/23/25 C2N at AAIC 2025 in Toronto Read More Joni Henderson 3/18/25 Joni Henderson 3/18/25 C2N at AD/PD 2025 in Vienna Read More Joni Henderson 12/23/24 Joni Henderson 12/23/24 C2N Year in Review Read More Joni Henderson 10/21/24 Joni Henderson 10/21/24 C2N at CTAD 2024 in Madrid Read More Joni Henderson 9/4/24 Joni Henderson 9/4/24 JAMA Published Landmark Clinical Study on Alzheimer’s Disease Diagnosis Using the PrecivityAD2™ Blood Test Read More Joni Henderson 7/16/24 Joni Henderson 7/16/24 C2N at AAIC in Philadelphia July 28–Aug. 1 C2N at AAIC in Philadelphia July 28–Aug. 1 Read More Lee Q 10/18/23 Lee Q 10/18/23 Join our C₂N Diagnostics team at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) October 24 – 27 in Boston Read More David Feinstein 11/17/22 David Feinstein 11/17/22 Join our C₂N Diagnostics team at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco, November 29 – December 2 Read More Guest User 10/21/22 Guest User 10/21/22 C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments Read More Lee Q 4/23/21 Lee Q 4/23/21 PrecivityAD™ Test Success Leads to Attention and Growth Read More Lee Q 12/21/20 Lee Q 12/21/20 2020 Marks a Year of Achievement Read More Subscribe to our newsletter. Newsletter Block This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab. Sign up with your email address to receive news and updates. Email Address Sign Up We respect your privacy. Thank you!
Joni Henderson 9/4/24 Joni Henderson 9/4/24 JAMA Published Landmark Clinical Study on Alzheimer’s Disease Diagnosis Using the PrecivityAD2™ Blood Test Read More
Joni Henderson 7/16/24 Joni Henderson 7/16/24 C2N at AAIC in Philadelphia July 28–Aug. 1 C2N at AAIC in Philadelphia July 28–Aug. 1 Read More
Lee Q 10/18/23 Lee Q 10/18/23 Join our C₂N Diagnostics team at the 16th Clinical Trials on Alzheimer’s Disease (CTAD) October 24 – 27 in Boston Read More
David Feinstein 11/17/22 David Feinstein 11/17/22 Join our C₂N Diagnostics team at the 15th Clinical Trials on Alzheimer’s Disease (CTAD) in San Francisco, November 29 – December 2 Read More
Guest User 10/21/22 Guest User 10/21/22 C₂N Diagnostics Marks Two Years of PrecivityAD® Blood Test Accomplishments Read More
